The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 11.7% year on year to $2.88 billion. The company’s full-year revenue guidance of $12.25 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.19 per share was significantly above analysts’ consensus estimates.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
will be announcing earnings results tomorrow before market open. Here’s what to expect.
Even during a down period for the markets, BrightSpring Health Services has gone against the grain, climbing to $17.29. Its shares have yielded a 8.7% return over the last six months, beating the S&P 500 by 17.6%. This run-up might have investors contemplating their next move.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at senior health, home health & hospice stocks, starting with Addus HomeCare (NASDAQ:ADUS).
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Brookdale (NYSE:BKD) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 9.4%. This performance was disheartening since the S&P 500 held its ground.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including AdaptHealth (NASDAQ:AHCO) and its peers.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 28.6% year on year to $3.05 billion. The company expects the full year’s revenue to be around $11.85 billion, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
will be announcing earnings results tomorrow before market open. Here’s what to expect.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.
Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q3 senior health, home health & hospice earnings season.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).
President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains.
BrightSpring will sell its Community Living business to Sevita for $835M in a deal set to close in 2025, boosting operational focus and revenue growth projections.
